Advances in Melanoma Treatment in 2025 скачать в хорошем качестве

Advances in Melanoma Treatment in 2025

Key Topics of Discussion: Advancements in Melanoma Treatment: Delve into the latest research and innovative therapies reshaping the future of melanoma care. Neoadjuvant Immunotherapy: Gain insights into how pre-surgery immunotherapy is improving patient outcomes. Second-Line Therapies for Metastatic Melanoma: Explore new treatment options for patients with advanced melanoma that no longer responds to initial therapies. Cancer Vaccines: Discover the evolving role of vaccines in melanoma treatment and their potential to prevent recurrence. Join us for an engaging discussion led by two renowned melanoma oncology experts, offering invaluable insights for patients, caregivers, and advocates alike. About Our Guests: Michael A. Davies, M.D., Ph.D. Professor and Chairman of the Department of Melanoma Medical Oncology, Division of Cancer Medicine Dr. Davies is a recognized leader in the management of advanced melanoma, specializing in immunotherapy, targeted therapies, and chemotherapy. He has designed and led numerous clinical trials aimed at improving outcomes for patients with advanced melanoma. Dr. Davies’ laboratory research focuses on understanding oncogenic mutations, overcoming resistance to treatments, and exploring new therapeutic strategies for melanoma, including those targeting central nervous system metastases. Hussein A. Tawbi, M.D., Ph.D. Professor and Deputy Chair of the Department of Melanoma Medical Oncology, Division of Cancer Medicine Dr. Tawbi is an expert in personalized cancer therapies for melanoma, with a focus on developing tailored treatments for patients based on genetic and molecular characteristics. As a director of personalized cancer therapy at MD Anderson, Dr. Tawbi’s research aims to improve treatment strategies for metastatic melanoma and investigate new ways to personalize and optimize therapy for each patient.